Head-to-head dispatch
Mint Med vs NexLife
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Mint Med is a national, no-membership compounded-GLP-1 telehealth platform offering semaglutide and tirzepatide on a flat "all doses" price — avoiding the per-tier escalation common as patients titrate up.
Marked down on: Easily confused with Mint Medical Clinic (a separate Utah-only med spa)
FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.
Desk Score
NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).
Marked down on: State availability not publicly disclosed
FDAWarning letter issued to Nexlife Inc. dba Nexlife in June 2026. See the FDA warning-letter database.
Mint Med takes this head-to-head with the higher Desk Score, 77/100 (C+) against 62/100 (C) for NexLife. NexLife still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Mint Med
77/100
C+
NexLife
62/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Mint Med | NexLife |
|---|---|---|
| Semaglutide | $159/mo | $165/mo (compounded) |
| Tirzepatide | $159/mo | $215/mo (compounded) |
| Coverage | 36 states | Coverage not published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want flat $159 all-doses compounded GLP-1 with no membership. | Readers who want pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1. |
| Desk Score | 77/100C+ | 62/100C |
The verdict
Desk pick — Mint MedMint Med takes this head-to-head with the higher Desk Score, 77/100 (C+) against 62/100 (C) for NexLife. NexLife still holds its ground where its strengths line up with yours.
Choose Mint Med if…
Readers who want flat $159 all-doses compounded GLP-1 with no membership.
$159/mo sema · $159/mo tirz · 36 states
FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.
Choose NexLife if…
Readers who want pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1.
$165/mo (compounded) sema · $215/mo (compounded) tirz · Coverage not published
FDAWarning letter issued to Nexlife Inc. dba Nexlife in June 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Mint Med · NexLife.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Mint Med vs CoreAge Rx
- NexLife vs Vaylen
- Mint Med vs Strut Health
- NexLife vs Ondra Health
- Mint Med vs Invigor Medical
- NexLife vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.